This $1,710,727 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will fund research conducted by Health Research, Inc. at Roswell Park in Buffalo, NY to investigate the role of the BRSK2 protein in aggressive breast cancer brain metastasis. The three-year project aims to develop new therapeutic approaches for treating this difficult-to-treat condition. Health Research, Inc. has a strong track record of executing complex cancer research projects, both as a prime grantee and subcontractor, for federal agencies like the National Institutes of Health and Department of Defense. This grant leverages the organization's multidisciplinary expertise in cancer biology, immunology, and clinical research to drive innovation in breast cancer treatment and outcomes.
Generated 4/1/25, 4:32 AM